Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Stock Now Rated “Moderate Buy” by Wall Street Analysts

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) has received an average rating of “Moderate Buy” from the twelve analysts that are currently covering the firm, MarketBeat.com reports. Five equities research analysts have rated the stock with a hold recommendation, six have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $14.06.

Several brokerages recently commented on AVAH. Raymond James Financial raised their price objective on shares of Aveanna Healthcare from $13.00 to $15.00 and gave the company a “strong-buy” rating in a research note on Friday, August 14th. JPMorgan Chase & Co. increased their target price on shares of Aveanna Healthcare from $8.00 to $15.00 and gave the company a “neutral” rating in a report on Monday, September 14th. BMO Capital Markets lifted their price target on shares of Aveanna Healthcare from $10.00 to $14.00 and gave the company an “outperform” rating in a research report on Friday, August 14th. Barclays boosted their price target on Aveanna Healthcare from $9.50 to $15.00 and gave the stock an “overweight” rating in a research note on Friday, August 28th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Aveanna Healthcare in a report on Thursday, July 2nd.

Aveanna Healthcare Trading Down 3.2%

AVAH opened at $12.38 on Friday. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 4.47. Aveanna Healthcare has a 52 week low of $5.93 and a 52 week high of $14.71. The business’s 50 day moving average is $11.91 and its two-hundred day moving average is $8.94. The firm has a market cap of $2.70 billion, a price-to-earnings ratio of 10.07, a price-to-earnings-growth ratio of 0.81 and a beta of 1.97.

Aveanna Healthcare (NASDAQ:AVAH) last announced its earnings results on Thursday, August 13th. The company reported $0.22 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.05. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. The business had revenue of $670.48 million during the quarter, compared to the consensus estimate of $638.61 million. On average, research analysts predict that Aveanna Healthcare will post 0.77 EPS for the current year.

Insider Activity

In related news, major shareholder Paul Vigano sold 2,250,000 shares of Aveanna Healthcare stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $11.50, for a total transaction of $25,875,000.00. Following the completion of the sale, the insider owned 12,315,892 shares in the company, valued at approximately $141,632,758. This trade represents a 15.45% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Edwin Reisz sold 50,000 shares of Aveanna Healthcare stock in a transaction dated Thursday, August 20th. The stock was sold at an average price of $11.50, for a total transaction of $575,000.00. Following the sale, the insider owned 1,397,897 shares of the company’s stock, valued at approximately $16,075,815.50. This trade represents a 3.45% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 56,985,116 shares of company stock worth $625,946,402 in the last quarter. 5.30% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Aveanna Healthcare

A number of institutional investors have recently added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd raised its position in Aveanna Healthcare by 252.4% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock valued at $27,000 after acquiring an additional 2,400 shares in the last quarter. Diversified Trust Co raised its holdings in shares of Aveanna Healthcare by 14.9% during the 1st quarter. Diversified Trust Co now owns 22,293 shares of the company’s stock valued at $144,000 after purchasing an additional 2,893 shares in the last quarter. EverSource Wealth Advisors LLC lifted its stake in shares of Aveanna Healthcare by 25.4% in the 4th quarter. EverSource Wealth Advisors LLC now owns 14,380 shares of the company’s stock valued at $117,000 after purchasing an additional 2,914 shares during the last quarter. Precision Wealth Strategies LLC boosted its holdings in Aveanna Healthcare by 4.6% in the first quarter. Precision Wealth Strategies LLC now owns 137,706 shares of the company’s stock worth $887,000 after purchasing an additional 6,115 shares in the last quarter. Finally, Arizona State Retirement System increased its position in Aveanna Healthcare by 46.4% during the second quarter. Arizona State Retirement System now owns 21,006 shares of the company’s stock worth $180,000 after buying an additional 6,661 shares during the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare Corporation is a provider of home-based healthcare services for children, adults and families in the United States. The company’s services are designed to help patients receive medical and supportive care in their homes and communities, including individuals with complex, chronic or medically fragile conditions.

Aveanna’s principal services include private-duty nursing, home health, hospice and personal care. It also provides pediatric therapy and related clinical services, including physical, occupational and speech therapy.